Target was Hit on Immunity Bio $IBRX at $6.25 for a 16.4% Gain.

POST UPDATED: April 9, 2024

Target was Hit on Immunity Bio $IBRX at $6.25 for a 16.4% Gain.

Related Articles

S T Chart

Swing Trade Buy on the Close for CrowdStrike Holdings $CRWD.

S T Chart

Swing Trade Buy on the Close for Cybersecurity Fund $BUG.

S T Chart

Top Pick of the Week is still Marvell Tech $MRVL will be bought on the Open today, and Sold on the Close Friday.